ABG Sundal Collier has initiated coverage of Bravida with a buy recommendation and a target price of 110 Swedish kronor, according to Bloomberg News (BN).

ABG Sundal Collier initiates coverage of Bravida with a buy rating and a target price of 110 kronor, BN reports.